Stifel Financial Corp Macrogenics Inc Transaction History
Stifel Financial Corp
- $86.8 Billion
- Q2 2024
A detailed history of Stifel Financial Corp transactions in Macrogenics Inc stock. As of the latest transaction made, Stifel Financial Corp holds 33,310 shares of MGNX stock, worth $112,587. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,310
Previous 36,095
7.72%
Holding current value
$112,587
Previous $531,000
73.45%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding MGNX
# of Institutions
154Shares Held
60.6MCall Options Held
218KPut Options Held
259K-
Bellevue Group Ag Kuesnacht, V89.94MShares$33.6 Million0.71% of portfolio
-
Armistice Capital, LLC New York, NY6MShares$20.3 Million0.33% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$18.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.14MShares$14 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.31MShares$11.2 Million0.01% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $208M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...